Schistosomiasis Industry Anticipated To Witness Noteworthy Growth In The Coming Years

Overview

Schistosomiasis is a type of infection caused by parasites that live in fresh water, such as rivers or lakes. Symptoms include a high temperature, headache, cough, a dark red, blotchy, raised skin rash, pain in the abdomen and joint and muscle pain.

 Click here for sample report @ http://www.wiseguyreports.com/sample-request/2319072-schistosomiasis-pipeline-review-h2-2017

Report Highlights

The Pharmaceutical and Healthcare latest pipeline guide Schistosomiasis - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Schistosomiasis (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Schistosomiasis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Schistosomiasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Preclinical and Discovery stages are 2, 5 and 2 respectively. Similarly, the Universities portfolio in Phase II and Phase I stages comprises 1 and 1 molecules, respectively.

Major Scope of the report:

- The pipeline guide provides a snapshot of the global therapeutic landscape of Schistosomiasis (Infectious Disease). 
- The pipeline guide reviews pipeline therapeutics for Schistosomiasis (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources. 
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. 
- The pipeline guide reviews key companies involved in Schistosomiasis (Infectious Disease) therapeutics and enlists all their major and minor projects.  

Table of Contents 

List of Figures 
Introduction 
Global Markets Direct Report Coverage 
Schistosomiasis - Overview 
Schistosomiasis - Therapeutics Development 
Pipeline Overview 
Pipeline by Companies 
Pipeline by Universities/Institutes 
Products under Development by Companies 
Products under Development by Universities/Institutes 
Schistosomiasis - Therapeutics Assessment 
Assessment by Target 
Assessment by Route of Administration 
Assessment by Molecule Type 
Schistosomiasis - Companies Involved in Therapeutics Development 
Kancera AB 
Knight Therapeutics Inc 
LondonPharma Ltd  

 .Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2319072-schistosomiasis-pipeline-review-h2-2017

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.